Glomerular Filtration Rate
2
Pipeline Programs
1
Companies
4
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
MediBeaconGermany - Mannheim
4 programs2
Below target dose MP-3180Phase 11 trial
MP-3180Phase 11 trial
LumitraceN/A1 trial
LumitraceN/A1 trial
Active Trials
+1 more trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
MediBeaconBelow target dose MP-3180
MediBeaconMP-3180
MediBeaconLumitrace
MediBeaconLumitrace
Clinical Trials (4)
Total enrollment: 72 patients across 4 trials
Pharmacokinetics of MP-3180 and Use of Noninvasive Fluorescence Detection Device in Healthy Volunteers
Start: Mar 2014Est. completion: Mar 201416 patients
Phase 1Completed
Pharmacokinetics of MP-3180 in Healthy Volunteers
Start: Nov 2013Est. completion: Jan 201416 patients
Phase 1Completed
MediBeacon® Transdermal GFR System for the Evaluation of Kidney Function in Adults With Heart Failure
Start: Feb 2026Est. completion: Jan 202715 patients
N/ANot Yet Recruiting
Evaluation of Protein Loading on Measurement of Renal Reserve
Start: Feb 2026Est. completion: Jan 202725 patients
N/ANot Yet Recruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space